Literature DB >> 714190

A benzodiazepine derivative and praziquantel: effects on musculature of Schistosoma mansoni and Schistosoma japonicum.

R Pax, J L Bennett, R Fetterer.   

Abstract

The benzodiazepine derivative (Ro 11-3128) which has central nervous effects similar to other benzodiazepines, and praziquantel (PZ), are two new antischistosomal drugs. At low concentrations these drugs will produce a marked spastic paralysis of male Schistosoma mansoni musculature. An analysis of the action of these drugs on the parasite's musculature shows that Ro 11-3128 and PZ produced a rapid rise in the tension of the musculature of male schistosomes. Various compounds known to interact with the schistosome's neuroreceptive sites did not block of potentiate the action of these drugs. Removal of Ca2+ or addition of Mg2+ to the incubation medium blocked the action of these drugs on the schistosome's musculature. Uptake studies of inorganic cations by male schistosome's indicate that Ro 11-3128 and PZ decrease the influx of K+ but stimulate the influx of Ca2+ and Na+ into the male schistosome. It is suggested that this interference with inorganic ion transport mechanisms causes the contraction of the schistosome musculature.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 714190     DOI: 10.1007/bf00507974

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  8 in total

Review 1.  ENZYMATIC BASIS FOR ACTIVE TRANSPORT OF NA+ AND K+ ACROSS CELL MEMBRANE.

Authors:  J C SKOU
Journal:  Physiol Rev       Date:  1965-07       Impact factor: 37.312

2.  Quantal components of the end-plate potential.

Authors:  J DEL CASTILLO; B KATZ
Journal:  J Physiol       Date:  1954-06-28       Impact factor: 5.182

3.  Characterization and isolation of concanavalin A binding sites from the epidermis of S. mansoni.

Authors:  J L Bennett; J L Seed
Journal:  J Parasitol       Date:  1977-04       Impact factor: 1.276

4.  Schistosoma mansoni: direct method for simultaneous recording of electrical and motor activity.

Authors:  R H Fetterer; R A Pax; J L Bennett
Journal:  Exp Parasitol       Date:  1977-10       Impact factor: 2.011

5.  The possible role of acetylcholine in Schistosoma mansoni.

Authors:  L R Barker; E Bueding; A R Timms
Journal:  Br J Pharmacol Chemother       Date:  1966-03

6.  A23187: a divalent cation ionophore.

Authors:  P W Reed; H A Lardy
Journal:  J Biol Chem       Date:  1972-11-10       Impact factor: 5.157

7.  Tryptaminergic and dopaminergic responses of Schistosoma mansoni.

Authors:  T K Tomosky; J L Bennett; E Bueding
Journal:  J Pharmacol Exp Ther       Date:  1974-08       Impact factor: 4.030

8.  Praziquantel, a new board-spectrum antischistosomal agent.

Authors:  R Gönnert; P Andrews
Journal:  Z Parasitenkd       Date:  1977-07-21
  8 in total
  47 in total

Review 1.  Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance.

Authors:  Nuno Vale; Maria João Gouveia; Gabriel Rinaldi; Paul J Brindley; Fátima Gärtner; José M Correia da Costa
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

2.  Inhibition of in vitro RNA synthesis by hycanthone, oxamniquine and praziquantel.

Authors:  L J Wong; G C Tsao; J I Bruce; S S Wong
Journal:  Experientia       Date:  1990-05-15

3.  Antibody response in mice infected with Mesocestoides vogae (syn. Mesocestoides corti) tetrathyridia after treatment with praziquantel and liposomised glucan.

Authors:  Gabriela Hrckova; Samuel Velebný; Grigorij Kogan
Journal:  Parasitol Res       Date:  2007-01-25       Impact factor: 2.289

Review 4.  Schistosomiasis drug therapy and treatment considerations.

Authors:  K C Shekhar
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

5.  Schistosoma mansoni: activity responses in vitro to praziquantel.

Authors:  C J Chavasse; M C Brown; D R Bell
Journal:  Z Parasitenkd       Date:  1979-02-28

6.  Transcriptional analysis of Schistosoma mansoni treated with praziquantel in vitro.

Authors:  Jarrett Hines-Kay; Pauline M Cupit; Melissa C Sanchez; George H Rosenberg; Ben Hanelt; Charles Cunningham
Journal:  Mol Biochem Parasitol       Date:  2012-09-27       Impact factor: 1.759

7.  Molecular modeling and infrared and Raman spectroscopy of the crystal structure of the chiral antiparasitic drug Praziquantel.

Authors:  Ana Borrego-Sánchez; Alfonso Hernández-Laguna; C Ignacio Sainz-Díaz
Journal:  J Mol Model       Date:  2017-03-08       Impact factor: 1.810

8.  Central effects in man of the novel schistosomicidal benzodiazepine meclonazepam.

Authors:  C O'Boyle; R Lambe; A Darragh
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 9.  Ca²⁺ channels and praziquantel: a view from the free world.

Authors:  John D Chan; Magdalena Zarowiecki; Jonathan S Marchant
Journal:  Parasitol Int       Date:  2012-12-16       Impact factor: 2.230

10.  Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni.

Authors:  Sandra D Melman; Michelle L Steinauer; Charles Cunningham; Laura S Kubatko; Ibrahim N Mwangi; Nirvana Barker Wynn; Martin W Mutuku; Diana M S Karanja; Daniel G Colley; Carla L Black; William Evan Secor; Gerald M Mkoji; Eric S Loker
Journal:  PLoS Negl Trop Dis       Date:  2009-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.